We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
+7.8%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$760M
AUM Growth
–
Cap. Flow
+$748M
Cap. Flow
% of AUM
98.49%
Top 10 Holdings %
Top 10 Hldgs %
68.93%
Holding
31
New
31
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$48.3M |
| 2 |
ELGX
Endologix Inc
ELGX
|
+$48M |
| 3 |
Quest Diagnostics
DGX
|
+$43.7M |
| 4 |
Medtronic
MDT
|
+$37.6M |
| 5 |
Integer Holdings
ITGR
|
+$37M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.03% |
| 2 | Technology | 2.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $122M | 16.1% |
+600,000
| New | +$123M |
|
2
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $95.1M | 12.51% |
+788,300
| New | +$96.1M |
|
|
PDCO
3
DELISTED
Patterson Companies, Inc.
PDCO
| $47.5M | 6.25% |
+1,050,000
| New | +$48.3M |
|
|
4
Quest Diagnostics
DGX
$25.7B
| $46.2M | 6.09% |
+650,000
| New | +$43.7M |
|
|
ELGX
5
DELISTED
Endologix Inc
ELGX
| $44.3M | 5.83% |
+447,500
| New | +$48M |
|
|
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
| $42.2M | 5.55% |
+1,925,000
| New | +$35.9M |
|
|
7
Medtronic
MDT
$109B
| $38.5M | 5.06% |
+500,000
| New | +$37.6M |
|
|
8
Integer Holdings
ITGR
$4.12B
| $35.4M | 4.66% |
+740,475
| New | +$37M |
|
|
MDRX
9
DELISTED
Veradigm Inc. Common Stock
MDRX
| $28.5M | 3.74% |
+1,850,000
| New | +$26.5M |
|
10
Alkermes
ALKS
$8.22B
| $23.8M | 3.13% |
+300,000
| New | +$21M |
|
|
SPNC
11
DELISTED
Spectranetics Corp
SPNC
| $20.3M | 2.68% |
+1,350,000
| New | +$17.8M |
|
|
LMNX
12
DELISTED
Luminex Corp
LMNX
| $19.8M | 2.6% |
+925,000
| New | +$18.6M |
|
|
IMPR
13
DELISTED
IMPRIVATA, INC COM
IMPR
| $19.7M | 2.6% |
+1,746,000
| New | +$20.6M |
|
14
Becton Dickinson
BDX
$45.6B
| $19.3M | 2.54% |
+128,125
| New | +$18.4M |
|
15
Bio-Rad Laboratories Class A
BIO
$8.71B
| $17.3M | 2.28% |
+125,000
| New | +$17.3M |
|
16
Perrigo
PRGO
$1.4B
| $17.1M | 2.25% |
+118,000
| New | +$18.1M |
|
17
Steris
STE
$22.3B
| $15.8M | 2.07% |
+209,169
| New | +$15.1M |
|
18
AtriCure
ATRC
$1.92B
| $15.7M | 2.07% |
+700,000
| New | +$14.4M |
|
19
AstraZeneca
AZN
$263B
| $13.6M | 1.79% |
+200,000
| New | +$13.1M |
|
|
CORI
20
DELISTED
Corium International, Inc.
CORI
| $11.2M | 1.48% |
+1,385,000
| New | +$10.9M |
|
|
AMRN
21
Amarin Corp
AMRN
$299M
| $10.4M | 1.37% |
+275,000
| New | +$10.8M |
|
|
ALR
22
DELISTED
Alere Inc
ALR
| $8.79M | 1.16% |
+225,000
| New | +$9.66M |
|
|
ESRX
23
DELISTED
Express Scripts Holding Company
ESRX
| $8.74M | 1.15% |
+100,000
| New | +$8.57M |
|
|
24
CALL
Becton Dickinson
BDX
$45.6B
| $7.71M | 1.01% |
+51,250
| New | +$7.38M |
|
|
SGNT
25
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $7.16M | 0.94% |
+450,000
| New | +$7.08M |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU
Tamarack Advisers's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for Tamarack Advisers, which disclosed 31 positions worth $760M. Its ten largest holdings account for 69% of the portfolio.
Its largest position is Patterson Companies, Inc.: 1,050,000 shares worth $47.5M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, followed by Technology.
- Tamarack Advisers's largest Q4 2015 buy was Patterson Companies, Inc.: 1,050,000 shares worth $47.5M.
- Tamarack Advisers's ten largest holdings make up 69% of its $760M portfolio in Q4 2015.
- Tamarack Advisers disclosed 31 positions in Q4 2015, its first 13F filing on record.
Based on Tamarack Advisers's 13F filing for Q4 2015, filed 8 Feb 2016.